Solid Dosage Forms: Formulation and Characterization

  • Shambhavi Borde
  • Dhirender Singh
  • Navneet Sharma
  • Dunesh Kumari
  • Harsh ChauhanEmail author
Living reference work entry


The chapter provide introduction and need of solid dosage forms for space pharmaceuticals. It discusses various drugs and excipients which can be utilized in these solid dosage forms. The chapter further emphasis on important formulation development aspects of solid dosage forms. It discusses important analytical characterization techniques utilized in solid dosage forms. Overall, solid dosage forms are key to space travel due to long-term stability advantage it offers in space conditions.


  1. Ahrabi SF, Sande SA, Waaler T, Graffner C (1999) Effects of thermal neutron irradiation on some potential excipients for colonic delivery systems. Drug Dev Ind Pharm 25(4):453–462CrossRefGoogle Scholar
  2. Allinson JG, Dansereau RJ, Sakr A (2001) The effects of packaging on the stability of a moisture sensitive compound. Int J Pharm 221(1–2):49–56CrossRefGoogle Scholar
  3. Barbarina N, Tilquin B, de Hoffmann E (2001) Radiosterilization of cefotaxime: investigation of potential degradation compounds by liquid chromatography-electrospray mass spectrometry. J Chromatogr A 929(1–2):51–61CrossRefPubMedCentralGoogle Scholar
  4. Barger LK, Flynn-Evans EE, Kubey A, Walsh L, Ronda JM, Wang W, Wright KP Jr, Czeisler CA (2014) Prevalence of sleep deficiency and use of hypnotic drugs in astronauts before, during, and after spaceflight: an observational study. Lancet Neurol 13:904–912CrossRefPubMedCentralGoogle Scholar
  5. Benton ER, Benton EV (2001) Space radiation dosimetry in low-earth orbit and beyond. Nucl Inst Methods Phys Res B 184(1–2):255–294CrossRefGoogle Scholar
  6. Chan H-K, Chew NYK (2002) Excipients: powders and solid dosage forms. In: Swarbrick J (ed.) Encyclopedia of pharmaceutical technology, 3rd ed., Informa Healthcare USA, Inc, New York 2007; 3:1646–1655Google Scholar
  7. Du B, Daniels VR, Vaksman Z, Boyd JL, Crady C, Putcha L (2011) Evaluation of physical and chemical changes in pharmaceuticals flown on space missions. AAPS J 13(2):299CrossRefPubMedCentralGoogle Scholar
  8. Gibson M (2009) Pharmaceutical preformulation and formulation. Informa Healthcare, New YorkGoogle Scholar
  9. Gullapalli RP, Gelatin MCL (2017) Non-gelatin capsule dosage forms. J Pharm Sci 106(6):1453–1465. Epub 2017 Feb 14CrossRefPubMedPubMedCentralGoogle Scholar
  10. Hargens AR, Richardson S (2009) Cardiovascular adaptations, fluid shifts, and countermeasures related to space flight. Respir Physiol Neurobiol 169(Suppl 1):S30–S33CrossRefPubMedCentralGoogle Scholar
  11. Kane MP, Tsuji K (1983) Radiolytic degradation scheme for 60Coirradiated corticosteroids. J Pharm Sci 72(1):30–35CrossRefPubMedCentralGoogle Scholar
  12. Kasta J, Yua Y, Seubertb CN, Wotring VE, Derendorfa H (2017) Drugs in space: pharmacokinetics and pharmacodynamics in astronauts. Eur J Pharm Sci 109:S2–S8CrossRefGoogle Scholar
  13. Lyon RC, Taylor JS, Porter DA, Prasanna HR, Hussain AS (2006) Stability profiles of drug products extended beyond labeled expiration dates. J Pharm Sci 95(7):1549–1560CrossRefPubMedCentralGoogle Scholar
  14. Maggi L, Segale L, Ochoa ME, Buttafava A, Faucitano A, Conte U (2003) Chemical and physical stability of hydroxypropylmethylcellulose matrices containing diltiazem hydrochloride after gamma irradiation. J Pharm Sci 92(1):131–141CrossRefPubMedCentralGoogle Scholar
  15. Martin A, Sullivan P, Beaudry C, Kuyumjian R, Comtois J-M (2012) Space medicine innovation and telehealth concept implementation for medical care during exploration-class missions. Acta Astronaut 81:30–33CrossRefGoogle Scholar
  16. Mehta P, Bhayani D (2017) Impact of space environment on stability of medicines: challenges and prospects. J Pharm Biomed Anal 136:111–119CrossRefPubMedCentralGoogle Scholar
  17. Nagashree K (2015) Solid dosage forms: tablets. Research and reviews. J Pharm Anal 4:60Google Scholar
  18. National Council on Radiation Protection and Measurements (NCRP) (1989) Guidance on radiation received in space activities: report no. 98. NCRP, BethesdaGoogle Scholar
  19. Nicogossian AE, Williams RS, Huntoon CL, Doarn CR, Polk JD, Schneider VS (2016) Space physiology and medicine: from evidence to practice, 4th edn. Springer, New YorkCrossRefGoogle Scholar
  20. Okeke CC, Bailey L, Medwick T, Grady LT (2000) Revised USP standards for product dating, packaging, and temperature monitoring. Am J Health Syst Pharm 57(15):1441–1445PubMedPubMedCentralGoogle Scholar
  21. Parks OW (1985) Screening tests for sulfa drugs and/or dinitrobenzamide coccidiostats and their monoamino metabolites in chicken livers. J Assoc Off Anal Chem 68(1):20–23PubMedPubMedCentralGoogle Scholar
  22. Putcha L, Taylor PW (2011) Biopharmaceutical challenges of therapeutics in space: formulation and packaging considerations. Ther Deliv 2(11):1373–1376CrossRefPubMedCentralGoogle Scholar
  23. Putcha L, Berens KL, Marshburn TH, Ortega HJ, Billica RD (1999) Pharmaceutical use by U.S. astronauts on space shuttle missions. Aviat Space Environ Med 70:705–708PubMedPubMedCentralGoogle Scholar
  24. Shanmugam S (2015) Granulation techniques and technologies: recent progresses. Bioimpacts 5(1):55–63. Epub 2015 Feb 18CrossRefPubMedPubMedCentralGoogle Scholar
  25. Smith SM, Wastney ME, O’Brien KO, Morukov BV, Larina IM, Abrams SA, Davis-Street JE, Oganov V, Shackelford LC (2005) Bone markers, calcium metabolism, and calcium kinetics during extended-duration space flight on the Mir space station. J Bone Miner Res Off J Am Soc Bone Miner Res 20:208–218CrossRefGoogle Scholar
  26. Smith SM, Heer MA, Shackelford LC, Sibonga JD, Ploutz-Snyder L, Zwart SR (2012) Benefits for bone from resistance exercise and nutrition in long-duration spaceflight: evidence from biochemistry and densitometry. J Bone Miner Res Off J Am Soc Bone Miner Res 27:1896–1906CrossRefGoogle Scholar
  27. Van Weeren R, Sashidharan A 2008 Sensitivity profiling of solid oral doses. Pharm Process 1–5.
  28. Williams D, Kuipers A, Mukai C, Thirsk R (2009) Acclimation during space flight: effects on human physiology. CMAJ 180:1317–1323CrossRefPubMedCentralGoogle Scholar
  29. Wotring VE (2015) Medication use by U.S. crewmembers on the International Space Station. FASEB J 29:4417–4423CrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Shambhavi Borde
    • 1
  • Dhirender Singh
    • 2
  • Navneet Sharma
    • 3
  • Dunesh Kumari
    • 4
  • Harsh Chauhan
    • 1
    Email author
  1. 1.Creighton UniversityOmahaUSA
  2. 2.Navinta LLCEwingUSA
  3. 3.Formulation Scientist, Perrigo CompanyAlleganUSA
  4. 4.College of Saint MaryOmahaUSA

Section editors and affiliations

  • Yashwant Pathak
    • 1
  1. 1.Health College of PharmacyUniversity of South FloridaTampaUSA

Personalised recommendations